{
    "Trade/Device Name(s)": [
        "Lyphochek Diabetes Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K070546",
    "Predicate Device Reference 510(k) Number(s)": [
        "K862186"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGM"
    ],
    "Summary Letter Date": "April 2, 2007",
    "Summary Letter Received Date": "February 26, 2007",
    "Submission Date": "February 23, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.8625"
    ],
    "Regulation Name(s)": [
        "Hematology quality control mixture"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1C",
        "Hemoglobin A1",
        "Hemoglobin F",
        "Total Glycated Hemoglobin",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Lyphochek Diabetes Control as an assayed quality control material for specified hemoglobin analytes in whole blood.",
    "Indications for Use Summary": "Intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for specified analytes.",
    "fda_folder": "Hematology"
}